SSRI
Fluvoxamine maleate
Brand names: Faverin
Adult dose
Dose: OCD/depression: 50–100mg OD initial, increase to max 300mg/day (>150mg in divided doses)
Route: PO
Frequency: OD or divided
Clinical pearls
- First-line SSRI for OCD in some guidelines
- Significant CYP1A2 interactions — particularly clozapine
Contraindications
- Concurrent MAOI / pimozide / tizanidine
- Hypersensitivity
Side effects
- Nausea
- Insomnia
- Sweating
- Sexual dysfunction
- Bleeding risk
- Hyponatraemia
- QT prolongation
Interactions
- Potent CYP1A2 inhibitor — clozapine/theophylline/methadone/olanzapine raised levels
- MAOIs (avoid)
- Warfarin
- NSAIDs/aspirin (bleeding)
Monitoring
- Mental state
- BP
- Weight
Reference: BNF; NICE CG31/CG90; https://bnf.nice.org.uk/drugs/fluvoxamine-maleate/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185 / BNF